125 related articles for article (PubMed ID: 38655099)
1. Molecular interaction and MD-simulations: investigation of Sizofiran as a promising anti-cancer agent targeting eIF4E in colorectal cancer.
Samykannu G; Mariyappan N; Natarajan J
In Silico Pharmacol; 2024; 12(1):33. PubMed ID: 38655099
[TBL] [Abstract][Full Text] [Related]
2. A unique binding mode of the eukaryotic translation initiation factor 4E for guiding the design of novel peptide inhibitors.
Di Marino D; D'Annessa I; Tancredi H; Bagni C; Gallicchio E
Protein Sci; 2015 Sep; 24(9):1370-82. PubMed ID: 26013047
[TBL] [Abstract][Full Text] [Related]
3. Unraveling the therapeutic potential of
Balkrishna A; Sharma D; Thapliyal M; Arya V; Dabas A
In Silico Pharmacol; 2024; 12(1):3. PubMed ID: 38108042
[TBL] [Abstract][Full Text] [Related]
4. MNK, mTOR or eIF4E-selecting the best anti-tumor target for blocking translation initiation.
Li S; Chen JS; Li X; Bai X; Shi D
Eur J Med Chem; 2023 Nov; 260():115781. PubMed ID: 37669595
[TBL] [Abstract][Full Text] [Related]
5. A biphenyl inhibitor of eIF4E targeting an internal binding site enables the design of cell-permeable PROTAC-degraders.
Fischer PD; Papadopoulos E; Dempersmier JM; Wang ZF; Nowak RP; Donovan KA; Kalabathula J; Gorgulla C; Junghanns PPM; Kabha E; Dimitrakakis N; Petrov OI; Mitsiades C; Ducho C; Gelev V; Fischer ES; Wagner G; Arthanari H
Eur J Med Chem; 2021 Jul; 219():113435. PubMed ID: 33892272
[TBL] [Abstract][Full Text] [Related]
6. Targeting protein tyrosine phosphatase to unravel possible inhibitors for Streptococcus pneumoniae using molecular docking, molecular dynamics simulations coupled with free energy calculations.
Zaman Z; Khan S; Nouroz F; Farooq U; Urooj A
Life Sci; 2021 Jan; 264():118621. PubMed ID: 33164832
[TBL] [Abstract][Full Text] [Related]
7. In-silico identification of small molecule benzofuran-1,2,3-triazole hybrids as potential inhibitors targeting EGFR in lung cancer via ligand-based pharmacophore modeling and molecular docking studies.
Kumar S; Ali I; Abbas F; Khan N; Gupta MK; Garg M; Kumar S; Kumar D
In Silico Pharmacol; 2023; 11(1):20. PubMed ID: 37575679
[TBL] [Abstract][Full Text] [Related]
8. Docking simulation and ADMET prediction based investigation on the phytochemical constituents of Noni (
Chandran K; Shane DI; Zochedh A; Sultan AB; Kathiresan T
In Silico Pharmacol; 2022; 10(1):14. PubMed ID: 36034317
[TBL] [Abstract][Full Text] [Related]
9. Gating by tryptophan 73 exposes a cryptic pocket at the protein-binding interface of the oncogenic eIF4E protein.
Lama D; Brown CJ; Lane DP; Verma CS
Biochemistry; 2015 Oct; 54(42):6535-44. PubMed ID: 26427906
[TBL] [Abstract][Full Text] [Related]
10. Discovery and characterization of conserved binding of eIF4E 1 (CBE1), a eukaryotic translation initiation factor 4E-binding plant protein.
Patrick RM; Lee JCH; Teetsel JRJ; Yang SH; Choy GS; Browning KS
J Biol Chem; 2018 Nov; 293(44):17240-17247. PubMed ID: 30213859
[TBL] [Abstract][Full Text] [Related]
11. GC-MS analysis, pharmacokinetic properties, molecular docking and dynamics simulation of bioactives from
Rao RS; Saravanan D; Mohan M
In Silico Pharmacol; 2024; 12(1):16. PubMed ID: 38482466
[TBL] [Abstract][Full Text] [Related]
12. Repurposing of approved drugs for targeting CDK4/6 and aromatase protein using molecular docking and molecular dynamics studies.
Yousif FA; Alzain AA; Alraih AM; Ibraheem W
PLoS One; 2023; 18(9):e0291256. PubMed ID: 37682937
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation.
Wang X; Yue P; Chan CB; Ye K; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Fu H; Khuri FR; Sun SY
Mol Cell Biol; 2007 Nov; 27(21):7405-13. PubMed ID: 17724079
[TBL] [Abstract][Full Text] [Related]
14. Virtual screening of acetylcholinesterase inhibitors through pharmacophore-based 3D-QSAR modeling, ADMET, molecular docking, and MD simulation studies.
Kumar H; Datusalia AK; Khatik GL
In Silico Pharmacol; 2024; 12(1):13. PubMed ID: 38370859
[TBL] [Abstract][Full Text] [Related]
15. Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment.
Ziouziou H; Andrieu C; Laurini E; Karaki S; Fermeglia M; Oueslati R; Taieb D; Camplo M; Siri O; Pricl S; Katsogiannou M; Rocchi P
Oncotarget; 2017 Sep; 8(44):77317-77329. PubMed ID: 29100389
[TBL] [Abstract][Full Text] [Related]
16. Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer.
Culjkovic B; Borden KL
J Oncol; 2009; 2009():981679. PubMed ID: 20049173
[TBL] [Abstract][Full Text] [Related]
17. Exploring the pharmacological aspects of natural phytochemicals against SARS-CoV-2 Nsp14 through an in silico approach.
De A; Bhattacharya S; Debroy B; Bhattacharya A; Pal K
In Silico Pharmacol; 2023; 11(1):12. PubMed ID: 37131867
[TBL] [Abstract][Full Text] [Related]
18. Structure of the eukaryotic translation initiation factor eIF4E in complex with 4EGI-1 reveals an allosteric mechanism for dissociating eIF4G.
Papadopoulos E; Jenni S; Kabha E; Takrouri KJ; Yi T; Salvi N; Luna RE; Gavathiotis E; Mahalingam P; Arthanari H; Rodriguez-Mias R; Yefidoff-Freedman R; Aktas BH; Chorev M; Halperin JA; Wagner G
Proc Natl Acad Sci U S A; 2014 Aug; 111(31):E3187-95. PubMed ID: 25049413
[TBL] [Abstract][Full Text] [Related]
19. Computational investigation of
Yousaf MA; Anwer SA; Basheera S; Sivanandan S
J Biomol Struct Dyn; 2024; 42(4):1901-1923. PubMed ID: 37154824
[TBL] [Abstract][Full Text] [Related]
20. Improved eIF4E binding peptides by phage display guided design: plasticity of interacting surfaces yield collective effects.
Zhou W; Quah ST; Verma CS; Liu Y; Lane DP; Brown CJ
PLoS One; 2012; 7(10):e47235. PubMed ID: 23094039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
